Efficacy of EMF BCI Based Device on Acute Stroke
The Efficacy of ElectroMagnetic Field Brain Computer Interface Based Device in the Management of Acute Stroke Patients
Sponsor: BrainQ Technologies Ltd.
Terminated
The study was terminated at the interim point due to the covid-19 pandemic, which did not allow completing full recruitment in relevant timelines
Other Acute Stroke trials with similar outcome
Listed as NCT04039178, this NA trial focuses on Acute Stroke and remains terminated or withdrawn. Sponsored by BrainQ Technologies Ltd., it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Mar 2021 — Dec 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BrainQ Technologies Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .